References
- Ferreira LLG , AndricopuloAD. Drugs and vaccines in the 21st century for neglected diseases. Lancet Infect. Dis.19(2), 125–127 (2019).
- WHO . Ending the neglect to attain the Sustainable Development Goals: A road map for neglected tropical diseases 2021–2030.World Health Organization, Geneva, Switzerland (2020). www.who.int/publications/i/item/9789240010352
- UN . Sustainable Development Goals. https://sdgs.un.org/
- Benazzouz SM , MalkinsonJ , TóthG. Current trends in and future potential of crowdfunding to finance R&D of treatments for neglected tropical diseases. Drug Discov. Today26(7), 1563–1568 (2021).
- Aya Pastrana N , BeranD , SomervilleC , HellerO , CorreiaJC , SuggsLS. The process of building the priority of neglected tropical diseases: a global policy analysis. PLOS Negl. Trop. Dis.14(8), e0008498 (2020).
- Eisenstein M . Overlooked and underfunded: neglected diseases exert a toll. Nature598, S20–S22 (2021).
- Ferreira LLG , de MoraesJ , AndricopuloAD. Approaches to advance drug discovery for neglected tropical diseases. Drug Discov. Today27(8), 2278–2287 (2022).
- DNDi . LOLA: DNDi’s first innovative neglected disease early-stage research programme launches in Latin America. www.dndi.org/2013/media-centre/news-views-stories/news/first-early-stage-research-latin-america
- DNDi . NTD Drug Discovery Booster Hit-to-lead. https://dndi.org/research-development/portfolio/drug-discovery-booster
- World Intellectual Property Organization About WIPO Re: Search. www.wipo.int/research/en/about
- Wijnant GJ , CroftSL , dela Flor Ret al. Pharmacokinetics and pharmacodynamics of the nitroimidazole DNDI-0690 in mouse models of cutaneous leishmaniasis. Antimicrob. Agents Chemother.63(9), e00829–19 (2019).
- WHO . Leishmaniasis. www.who.int/news-room/fact-sheets/detail/leishmaniasis
- Palić S , BeijnenJH , DorloTPC. An update on the clinical pharmacology of miltefosine in the treatment of leishmaniasis. Int. J. Antimicrob. Agents59(1), 106459 (2022).
- DNDi . Visceral leishmaniasis. https://dndi.org/diseases/visceral-leishmaniasis/
- García-Huertas P , Cardona-CastroN. Advances in the treatment of Chagas disease: promising new drugs, plants and targets. Biomed. Pharmacother.142, 112020 (2021).
- DNDi . DNDI-6148 Chagas disease. https://dndi.org/research-development/portfolio/dndi-6148-chagas/
- WHO . Human African trypanosomiasis. www.who.int/health-topics/human-african-trypanosomiasis
- Valverde Mordt O , TarralA , Strub-WourgaftN. Development and introduction of fexinidazole into the Global Human African Trypanosomiasis Program. Am. J. Trop. Med. Hyg.106(Suppl. 5), 61–66 (2022).
- DNDi . Sleeping sickness Acoziborole. https://dndi.org/research-development/portfolio/acoziborole/